Ludovica Marando

1.2k total citations
17 papers, 223 citations indexed

About

Ludovica Marando is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ludovica Marando has authored 17 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Ludovica Marando's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Complement system in diseases (3 papers). Ludovica Marando is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Complement system in diseases (3 papers). Ludovica Marando collaborates with scholars based in United Kingdom, United States and Italy. Ludovica Marando's co-authors include Brian J.P. Huntly, George S. Vassiliou, Haiyang Yun, George Giotopoulos, Lorena Di Lisio, João M.L. Dias, Paolo Gallipoli, Faisal Basheer, Sarah J. Horton and Konstantinos Tzelepis and has published in prestigious journals such as Nature Genetics, Blood and British Journal of Haematology.

In The Last Decade

Ludovica Marando

14 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludovica Marando United Kingdom 5 141 127 71 55 27 17 223
Stefanie Herkt Germany 7 94 0.7× 135 1.1× 40 0.6× 38 0.7× 25 0.9× 11 232
Nicola Long United States 7 119 0.8× 85 0.7× 24 0.3× 48 0.9× 54 2.0× 17 203
Jutta Ortiz-Tánchez Germany 6 86 0.6× 157 1.2× 33 0.5× 35 0.6× 38 1.4× 8 245
Sally Jeffries United Kingdom 6 183 1.3× 66 0.5× 58 0.8× 57 1.0× 21 0.8× 10 235
Hai‐yan Chai China 8 281 2.0× 317 2.5× 138 1.9× 92 1.7× 15 0.6× 13 398
Zinia J. Kwidama Netherlands 10 230 1.6× 138 1.1× 47 0.7× 50 0.9× 36 1.3× 13 297
Ruzhica Bogeska Germany 6 139 1.0× 108 0.9× 17 0.2× 86 1.6× 58 2.1× 8 235
Janine O. Ilagan United States 5 113 0.8× 316 2.5× 49 0.7× 49 0.9× 29 1.1× 8 366
Himalee S. Sabnis United States 8 85 0.6× 123 1.0× 47 0.7× 14 0.3× 44 1.6× 20 234
Andy G.X. Zeng Canada 6 140 1.0× 132 1.0× 47 0.7× 23 0.4× 58 2.1× 16 230

Countries citing papers authored by Ludovica Marando

Since Specialization
Citations

This map shows the geographic impact of Ludovica Marando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovica Marando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovica Marando more than expected).

Fields of papers citing papers by Ludovica Marando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovica Marando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovica Marando. The network helps show where Ludovica Marando may publish in the future.

Co-authorship network of co-authors of Ludovica Marando

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovica Marando. A scholar is included among the top collaborators of Ludovica Marando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovica Marando. Ludovica Marando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kusne, Yael, Talha Badar, Terra L. Lasho, et al.. (2025). Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. British Journal of Haematology. 206(4). 1109–1120. 2 indexed citations
2.
Kusne, Yael, Talha Badar, Terra L. Lasho, et al.. (2024). Prevalence and Clinical Features of Non-Myeloid Neoplasms in Patients with DDX41 Mutant Germline Predisposition Syndrome. Blood. 144(Supplement 1). 440–440.
3.
Badar, Talha, Terra L. Lasho, Yael Kusne, et al.. (2024). PPM1D Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic TP53 Mutations. Blood. 144(Supplement 1). 3218–3218. 1 indexed citations
4.
Marando, Ludovica, Clifford M. Csizmar, & Mrinal M. Patnaik. (2024). Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica. 110(1). 22–36. 1 indexed citations
5.
Kusne, Yael, Talha Badar, Terra L. Lasho, et al.. (2024). Clinical Characteristics of Myeloproliferative Neoplasms in Patients with DDX41MT Germline Predisposition Syndrome. Blood. 144(Supplement 1). 3183–3183.
6.
Gu, Muxin, William G. Dunn, Ludovica Marando, et al.. (2023). Prevalence and significance of DDX41 gene variants in the general population. Blood. 142(14). 1185–1192. 24 indexed citations
7.
Gu, Muxin, William G. Dunn, Ludovica Marando, et al.. (2023). Multiparameter prediction of myeloid neoplasia risk. Nature Genetics. 55(9). 1523–1530. 46 indexed citations
8.
Dunn, William G., Muxin Gu, Ludovica Marando, et al.. (2023). Machine Learning for Identification of High-Risk Clonal Haematopoiesis Using Blood Count Data. Blood. 142(Supplement 1). 1318–1318.
9.
Badar, Talha, Terra L. Lasho, Yael Kusne, et al.. (2023). Clinical and Molecular Spectrum of Somatic Mosaic States in DDX41 mutant Germline Predisposition Syndromes. Blood. 142(Supplement 1). 4618–4618. 1 indexed citations
10.
Meduri, Eshwar, Charles E. Breeze, Ludovica Marando, Simon Richardson, & Brian J.P. Huntly. (2022). The RNA editing landscape in acute myeloid leukemia reveals associations with disease mutations and clinical outcome. iScience. 25(12). 105622–105622. 4 indexed citations
11.
Marando, Ludovica & Brian J.P. Huntly. (2020). Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications. Current Oncology Reports. 22(6). 61–61. 30 indexed citations
12.
Yun, Haiyang, Shabana Vohra, Annalisa Mupo, et al.. (2019). Mutational Synergy Coordinately Remodels Chromatin Accessibility, Enhancer Landscape and 3-Dimensional DNA Topology to Alter Gene Expression during Leukemia Induction. Blood. 134(Supplement_1). 278–278. 2 indexed citations
13.
Gallipoli, Paolo, George Giotopoulos, Konstantinos Tzelepis, et al.. (2018). Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood. 131(15). 1639–1653. 101 indexed citations
14.
Pulini, Stefano, Ludovica Marando, Caterina Pascariello, et al.. (2011). Paroxysmal Nocturnal Hemoglobinuria after Autologous Stem Cell Transplantation: Extinction of the Clone during Treatment with Eculizumab – Pathophysiological Implications of a Unique Clinical Case. Acta Haematologica. 126(2). 103–109. 1 indexed citations
16.
Scalia, Guido, Ludovica Marando, Patrizia Ricci, et al.. (2008). Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond.. 53–54. 6 indexed citations
17.
Risitano, Antonio M., Elisa Seneca, Ludovica Marando, et al.. (2008). Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA. Blood. 112(11). 1042–1042. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026